Table I. Repeatability of ka, kd, and Kd measurements of CSP Ag (at high density) binding of anti-CSP mAbs in PBS buffer and 1:50-diluted NHS measured in triplicate.
Ag | Ab | Diluent | Mean ka (×105 M−1 s−1) | Mean kd (×10−4 s−1) | Mean Kd (nM) |
---|---|---|---|---|---|
PF16 | AB236 | PBS | 1.82 ± 0.08 (%CV = 4.4) | 1.98 ± 0.29 (%CV = 14.6) | 1.09 ± 0.19 (%CV = 17.4) |
PF16 | AB236 | NHS | 2.20 ± 0.02 (%CV = 0.9) | 3.90 ± 0.19 (%CV = 4.9) | 1.77 ± 0.08 (%CV = 4.5) |
NANP6 | AB334 | PBS | 0.817 ± 0.002 (%CV = 0.2) | <0.01a | <0.01a |
NANP6 | AB334 | NHS | 1.02 ± 0.01 (%CV = 1.0) | <0.01a | <0.01a |
CSP-FL | AB236 | PBS | 4.62 ± 0.10 (%CV = 2.2) | <0.01a | <0.01a |
CSP-FL | AB236 | NHS | 6.33 ± 0.91 (%CV = 14.4) | <0.01a | <0.01a |
CSP-FL | AB334 | PBS | 0.57 ± 0.03 (%CV = 5.3) | <0.01a | <0.01a |
CSP-FL | AB334 | NHS | 0.37 ± 0.04 (%CV = 10.8) | <0.01a | <0.01a |
SD and %CV were ND because of slower than resolvable dissociation rate (kd < 0.01 × 10−4 s−1).